Two-stage model-based clinical trial design to optimize phase I development of novel anticancer agents.

A.S. Zandvliet, M.O. Karlsson, J.H.M. Schellens, W Copalu, J.H. Beijnen, A.D.R. Huitema

Research output: Contribution to journal › Article › Academic › peer-review

Cite this

@article{98907aaf93734dcd81db35c94e66f406,

title = "Two-stage model-based clinical trial design to optimize phase I development of novel anticancer agents.",

author = "A.S. Zandvliet and M.O. Karlsson and J.H.M. Schellens and W Copalu and J.H. Beijnen and A.D.R. Huitema",

year = "2010",

language = "Undefined/Unknown",

volume = "28",

pages = "61--75",

journal = "Investigational New Drugs",

issn = "0167-6997",

publisher = "Springer",

number = "1",

}

TY - JOUR

T1 - Two-stage model-based clinical trial design to optimize phase I development of novel anticancer agents.

AU - Zandvliet, A.S.

AU - Karlsson, M.O.

AU - Schellens, J.H.M.

AU - Copalu, W

AU - Beijnen, J.H.

AU - Huitema, A.D.R.

PY - 2010

Y1 - 2010

M3 - Article

SN - 0167-6997

VL - 28

SP - 61

EP - 75

JO - Investigational New Drugs

JF - Investigational New Drugs

IS - 1

ER -